Afatinib Impurity 44 | CAS 162012-67-1 - Request Quote
Afatinib Impurity 44
| SZ CAT No: | SZ-A054068 |
| CAS No | 162012-67-1 |
| Mol.F. | C14H7ClF2N4O2 |
| Mol.Wt. | 336.7 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 1922928-56-0 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Afatinib Impurity 44 is chemically N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine. Afatinib Impurity 44 is supplied with detailed characterization data compliant with regulatory guideline. Afatinib Impurity 44 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Afatinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 162012-67-1
Purchase 162012-67-1
Order 162012-67-1
Enquire 162012-67-1
price of 162012-67-1
162012-67-1 Supplier
162012-67-1 Manufacturer
162012-67-1 Exporter
buy high quality Afatinib Impurity 44
Purchase Afatinib Impurity 44
Afatinib Impurity 44 suppliers
Afatinib Impurity 44 manufacturers
Afatinib Impurity 44 price
Order Afatinib Impurity 44
Enquire Afatinib Impurity 44
Afatinib Impurity 44 cost
Afatinib Impurity 44 Supplier
Afatinib Impurity 44 Distributor
Afatinib Impurity 44 for Method Validation
Afatinib Reference Standard
Afatinib Impurity 44 for ANDA Filing
Afatinib Impurity 44 for Forced Degradation Studies
Afatinib Impurity 44 Identification Standards
Afatinib Impurity 44 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


